TrialBreast cancer research : BCR2026

Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a detailed safety analysis of the randomized OptiTROP-Breast01 study.

Ying Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.